Waters (WAT) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.33%. A quarter ago, it was expected that this maker of products used in drug discovery and development would post earnings of $2.55 per share when it actually produced earnings of $2.63, delivering a surprise of 3.14%.Over ...

Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & Industrial GAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditions Raised full-year sales and EPS guidance, ...

Core Insights - The article emphasizes the importance of quantitative analysis in investment decisions, suggesting that mathematical data should guide investment strategies [1] - The author expresses skepticism towards sell-side analysis, indicating that it often lacks quality and reliability [1] - The focus is on identifying value stocks with growth potential across various market capitalizations, including large caps, midcaps, small caps, international stocks, gold miners, and REITs [1] Investment Strategy - The investment approach includes the use of hedging strategies, with a preference for ETFs that align with these needs [1] - The author aims to share insights on stocks that are undervalued yet possess growth potential, indicating a strategy that combines value investing with growth considerations [1]

The market expects Waters (WAT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on November 1, 2024, might help the stock move higher if these key numbers are be ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Waters (WAT) , which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider.This maker of products used in drug discovery and development has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 4.19%.For the most re ...

Core Insights - The article emphasizes the importance of fundamental analysis in making informed investment decisions, particularly in the U.S. stock market [1] - It highlights the author's background in IT as a unique advantage in understanding technology stocks while also exploring diverse sectors for investment opportunities [1] - The intention is to create accessible content for investors of all experience levels, fostering a collaborative exploration of market insights [1] Group 1 - The author has seven years of experience managing a family portfolio, which has led to a deep understanding of risk and reward dynamics [1] - The articles will be crafted with clarity and precision, avoiding jargon to enhance accessibility for all investors [1] - The author invites both seasoned and novice investors to join in an intellectual journey to uncover market secrets and achieve financial success [1]

Core Points - Five manatees were successfully transported over 1,000 miles to Florida as part of a conservation effort involving multiple zoological and marine institutions [1][2][3] - The manatees were rehabilitated by the Columbus Zoo, Cincinnati Zoo, ZooTampa, and SeaWorld Orlando, highlighting a collaborative approach to wildlife conservation [3][11] - The transportation was executed with meticulous planning, ensuring the safety and comfort of the manatees during the flight [9][8] Rehabilitation and Care - The manatees were placed in custom-built containers for safe travel and were monitored throughout the flight by animal care specialists [2][8] - Two male manatees, Nighthawk and Mr. Dobak, were transferred to SeaWorld Orlando after being rescued as orphaned calves in January 2023, and they have since gained significant weight [4][17] - Three female manatees, Nolia, Amethyst, and Waffles, received intensive care for approximately 10 months before being moved back to ZooTampa for final rehabilitation [5][7] Conservation Efforts - The Manatee Rescue & Rehabilitation Partnership (MRP) plays a crucial role in the rescue and rehabilitation of manatees, involving various organizations dedicated to wildlife conservation [12][13] - The Columbus Zoo has returned 39 manatees to Florida, while the Cincinnati Zoo has returned 27, demonstrating the effectiveness of these rehabilitation efforts [14] - The ongoing conservation work is vital as manatees face numerous threats, including habitat loss and human-related injuries [15][16] Logistics and Transportation - DHL Express facilitated the transport of the manatees, utilizing state-of-the-art containers and ensuring their well-being during the journey [2][9] - The manatees were secured on palettes and provided with a comfortable resting environment, including an 8-inch-thick foam bed and temperature control measures [8][9] - The logistics involved in the transfer highlight the importance of collaboration between conservation organizations and logistics companies [9][22]

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vaccines, personalized cancer therapies, and innovative drugs for genetic disorders. Novel digestion enzymes deliver complete RNA sequence coveragei for more confident characterization, while new LC-MS-grade reagents increase sensitivity and improve detection accuracy of RNA components.ii New waters_connect™ MAP Sequence software accelerates RNA oligonucleot ...

Core Insights - Waters Corporation has introduced the TA Instruments™ Discovery Core Rheometer, a modern and compact rheometer designed for routine quality control in various industries including batteries, pharmaceuticals, and food [2][5] - The new rheometer features an easy-to-use touchscreen interface with self-guided training and methods, making it accessible for users at all levels of expertise [2][5] - The Discovery Core Rheometer offers superior analytical performance with up to 2x better torque sensitivity compared to other rheometers on the market, while requiring only half the bench space of comparable modular systems [4][5] Product Features - The instrument is equipped with RheoGuide™ Software, which simplifies the testing process through pre-defined methods and real-time data analysis [5][8] - It is designed specifically for in-line manufacturing quality control, enhancing the assessment of battery electrode slurry performance and reducing waste and production costs [5] - The Discovery Core Rheometer is orderable now, with global availability expected in Q1 2025 [6] Market Position - The introduction of the Discovery Core Rheometer addresses a significant unmet need in the market for high-performance rheometers that are accessible to a broader range of testing laboratories [5] - Waters Corporation has a long-standing reputation in high-performance rheometers, aiming to inspire better decision-making through superior results [5][7]

MILFORD, Mass., Oct. 7, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q3 2024 financial results conference call live on Friday, November 1st, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 29th, 2024, at midnight Eastern Time. About Waters Corporation Waters Corporation (NYSE: WAT), a global leader in analytical instrum ...